Universal Health Services, Inc. Announces 2024 Third Quarter Financial Results

Consolidated Results of Operations, As Reported and As Adjusted - Three-month periods ended September 30, 2024 and 2023:

KING OF PRUSSIA, Penn., Oct. 24, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $258.7 million, or $3.80 per diluted share, during the third quarter of 2024, as compared to $167.0 million, or $2.40 per diluted share, during the third quarter of 2023. Net revenues increased by 11.2% to $3.963 billion during the third quarter of 2024, as compared to $3.563 billion during the third quarter of 2023.

As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our adjusted net income attributable to UHS during the third quarter of 2024 was $252.5 million, or $3.71 per diluted share, as compared to $177.5 million, or $2.55 per diluted share, during the third quarter of 2023.

As reflected on the Supplemental Schedule, included in our reported results during the third quarter of 2024 were: (i) an unrealized after-tax gain of $2.3 million, or $.03 per diluted share ($3.0 million pre-tax), resulting from an increase in the market value of certain equity securities (included in "Other (income) expense, net"), and; (ii) a favorable net after-tax impact of $3.9 million, or $.06 per diluted share, resulting from the net tax benefit recorded pursuant to "ASU 2016-09", Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting, net of the impact of executive compensation limitations pursuant to IRC section 162(m).

As reflected on the Supplemental Schedule, included in our reported results during the third quarter of 2023, was an after-tax loss of $10.5 million, or $.15 per diluted share ($13.8 million pre-tax), resulting from a decrease in the market value of certain equity securities.

As calculated on the attached Supplemental Schedule, our earnings before interest, taxes, depreciation & amortization ("EBITDA net of NCI", NCI is net income attributable to noncontrolling interests), was $528.6 million, or 13.3% of net revenues, during the third quarter of 2024, as compared to $410.1 million, or 11.5% of net revenues, during the third quarter of 2023. Our adjusted earnings before interest, taxes, depreciation & amortization ("Adjusted EBITDA net of NCI"), which excludes the impact of other (income) expense, net, was $526.5 million, or 13.3% of net revenues, during the third quarter of 2024, as compared to $421.5 million, or 11.8% of net revenues, during the third quarter of 2023.

Consolidated Results of Operations, As Reported and As Adjusted - Nine-month periods ended September 30, 2024 and 2023:

Reported net income attributable to UHS was $809.7 million, or $11.88 per diluted share, during the first nine months of 2024, as compared to $501.4 million, or $7.09 per diluted share, during the first nine months 2023. Net revenues increased by 10.7% to $11.714 billion during the first nine months of 2024, as compared to $10.578 billion during the comparable period of 2023.

As reflected on the Supplemental Schedule, our adjusted net income attributable to UHS during the first nine months of 2024 was $798.2 million, or $11.71 per diluted share, as compared to $524.5 million, or $7.42 per diluted share, during the comparable period of 2023.

As reflected on the Supplemental Schedule, included in our reported results during the first nine months of 2024 were: (i) an unrealized after-tax loss of $4.0 million, or $.06 per diluted share ($5.3 million pre-tax), resulting from a decrease in the market value of certain equity securities (included in "Other (income) expense, net"), and; (ii) a favorable net after-tax impact of $15.5 million, or $.23 per diluted share, resulting from the above-mentioned net tax benefit recorded in connection with ASU 2016-09, net of the impact of executive compensation limitations pursuant to IRC section 162(m).

As reflected on the Supplemental Schedule, our reported results during the first nine months of 2023, included an unrealized after-tax loss of $23.0 million, or $.33 per diluted share, ($30.1 million pre-tax) resulting from a decrease in the market value of certain equity securities.

As calculated on the attached Supplemental Schedule, our EBITDA net of NCI, was $1.628 billion, or 13.9% of net revenues, during the first nine months of 2024, as compared to $1.237 billion, or 11.7% of net revenues, during the first nine months of 2023. Our Adjusted EBITDA net of NCI, which excludes the impact of other (income) expense, net, was $1.631 billion, or 13.9% of net revenues, during the first nine months of 2024, as compared to $1.268 billion, or 12.0% of net revenues, during the comparable period of 2023.

Acute Care Services - Three and nine-month periods ended September 30, 2024 and 2023:

During the third quarter of 2024, at our acute care hospitals owned during both periods ("same facility basis"), adjusted admissions (adjusted for outpatient activity) increased by 1.5% while adjusted patient days increased by 2.0%, as compared to the third quarter of 2023. At these facilities, during the third quarter of 2024, net revenue per adjusted admission increased by 7.0% while net revenue per adjusted patient day increased by 6.5%, as compared to the third quarter of 2023. Net revenues generated from our acute care services, on a same facility basis, increased by 9.2% during the third quarter of 2024, as compared to the third quarter of 2023.

During the nine-month period ended September 30, 2024, at our acute care hospitals on a same facility basis, adjusted admissions increased by 3.1% while adjusted patient days increased by 2.3%, as compared to the first nine months of 2023. At these facilities, during the first nine months of 2024, net revenue per adjusted admission increased by 5.0% while net revenue per adjusted patient day increased by 5.8%, as compared to the first nine months of 2023. Net revenues generated from our acute care services, on a same facility basis, increased by 8.5% during the first nine months of 2024, as compared to the comparable period of 2023.

Behavioral Health Care Services - Three and nine-month periods ended September 30, 2024 and 2023:

During the third quarter of 2024, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 2.2% while adjusted patient days increased by 1.8%, as compared to the third quarter of 2023. At these facilities, during the third quarter of 2024, net revenue per adjusted admission increased by 8.0% and net revenue per adjusted patient day increased by 8.5%, as compared to the third quarter of 2023. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 10.5% during the third quarter of 2024, as compared to the third quarter of 2023.

During the nine-month period ended September 30, 2024, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 0.3% while adjusted patient days increased by 1.7%, as compared to the first nine months of 2023. At these facilities, during the first nine months of 2024, net revenue per adjusted admission increased by 10.1% and net revenue per adjusted patient day increased by 8.7%, as compared to the first nine months of 2023. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 10.6% during the first nine months of 2024, as compared to the comparable period of 2023.

Net Cash Provided by Operating Activities and Liquidity:

Net Cash Provided by Operating Activities:

During the nine-month period ended September 30, 2024, our net cash provided by operating activities was $1.409 billion as compared to $815 million during the first nine months of 2023. The $593 million net increase in our net cash provided by operating activities consisted of: (i) a favorable change of $353 million resulting from an increase in net income plus/minus depreciation and amortization expense, stock-based compensation expense, gains on sales of assets and businesses and costs related to extinguishment of debt; (ii) a favorable change of $205 million in accounts receivable; (iii) a favorable change of $66 million in other working capital accounts; (iv) an unfavorable change of $55 million in other assets and deferred charges, and; (v) $24 million of other combined net favorable changes.

Liquidity:

As previously disclosed on Form 8-K on October 1, 2024, in September, 2024, we completed the following financing transactions:

• public offering of $500 million aggregate principal amount of 4.625% senior secured notes due in 2029;
• public offering of $500 million aggregate principal amount of 5.050% senior secured notes due in 2034;
• amended our credit agreement to:
  • extend the maturity date to September, 2029 (from August, 2026 previously),
  • increase the revolving credit facility to $1.3 billion (from $1.2 billion previously), and;
  • reduce the outstanding borrowings pursuant the tranche A term loan facility by approximately $1.0 billion, to $1.2 billion, utilizing the proceeds generated from the issuance of the above-mentioned senior secured notes due in 2029 and 2034.

As of September 30, 2024, we had $1.01 billion of aggregate available borrowing capacity pursuant to our $1.3 billion revolving credit facility, net of outstanding borrowings and letters of credit.

Stock Repurchase Program:

In July, 2024, our Board of Directors authorized a $1.0 billion increase to our stock repurchase program. Pursuant to this program, shares of our Class B Common Stock may be repurchased, from time to time as conditions allow, on the open market or in negotiated private transactions.

During the third quarter of 2024, we have repurchased 658,000 shares at an aggregate cost of approximately $153.9 million (approximately $234 per share) pursuant to the program. During the first nine months of 2024, we have repurchased 1.731 million shares at an aggregate cost of approximately $348.9 million (approximately $202 per share) pursuant to the program.

As of September 30, 2024, we had an aggregate available repurchase authorization of approximately $1.074 billion.

Conference call information:

We will hold a conference call for investors and analysts at 9:00 a.m. eastern time on October 25, 2024. A live webcast of the call will be available on our website at www.uhs.com. To participate via telephone, please register in advance at this link.

Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call will be available for one full year following the live call.

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

One of the nation's largest and most respected providers of hospital and healthcare services, Universal Health Services, Inc. (the "Company") has built an impressive record of achievement and performance. Growing steadily since our inception into an esteemed Fortune 500 corporation, our annual revenues during 2023 were $14.282 billion. UHS ranked #299 on the Fortune 500; and #399 on Forbes' list of America's Largest Public Companies. UHS was again recognized as one of the World's Most Admired Companies by Fortune.

Our operating philosophy is as effective today as it was upon the Company's founding in 1979, enabling us to provide compassionate care to our patients and their loved ones. Our strategy includes building or acquiring high quality hospitals in rapidly growing markets, investing in the people and equipment needed to allow each facility to thrive, and becoming the leading healthcare provider in each community we serve.

Headquartered in King of Prussia, PA, UHS has approximately 96,700 employees and, through its subsidiaries, operates 27 inpatient acute care hospitals, 334 inpatient behavioral health facilities, 49 outpatient facilities and ambulatory care access points, an insurance offering, a physician network and various related services located in 39 states, Washington, D.C., the United Kingdom and Puerto Rico. It acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE:UHT). For additional information visit www.uhs.com.

This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 2-Forward Looking Statements and Risk Factors in our Form 10-Q for the quarter ended June 30, 2024 and in Item 1A-Risk Factors, and Item 7-Forward-Looking Statements and Risk Factors, in our Form 10-K for the year ended December 31, 2023), may cause the results to differ materially from those anticipated in the forward-looking statements. These statements are subject to risks and uncertainties and therefore actual results may differ materially. Readers should not place undue reliance on such forward-looking statements which reflect management's view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Many of the factors that could affect our future results are beyond our control or ability to predict, including, but not limited to:

• A significant portion of our revenues are derived from federal and state government programs including the Medicare and Medicaid programs. Payments from these programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions. Changes to these programs, if adopted, could materially affect program payments which could materially impact our results of operations.
• The increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms. Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.
• The outcome of known and unknown litigation, liabilities and other claims asserted against us and/or our subsidiaries, including, but not limited to, the matters related to Cumberland Hospital for Children and Adolescents, located in New Kent, Virginia, as previously disclosed on Form 8-K on September 30, 2024, and the matter related to the Pavilion Behavioral Health System, located in Champaign, Illinois, as previously disclosed on Forms 8-K on April 1, 2024, September 30, 2024 and October 11, 2024, and Forms 10-Q for the quarterly periods ended March 31, 2024 and June 30, 2024. Although we can make no assurances regarding the ultimate outcome of these matters, or what damages will ultimately be awarded, the final resolution of these matters could have a material adverse effect on the Company.

We believe that adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share, EBITDA net of NCI and Adjusted EBITDA net of NCI, which are non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect of material items impacting our net income attributable to UHS, such as, changes in the market value of shares of certain equity securities, the impact of ASU 2016-09 and other potential material items that are nonrecurring or non-operational in nature including, but not limited to, impairments of goodwill, long-lived and intangible assets, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, potential impacts of non-ordinary acquisitions, divestitures, joint ventures or other strategic transactions, and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in connection with net income attributable to UHS, as determined in accordance with GAAP, and as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-Q for the quarter ended June 30, 2024 and our Report on Form 10-K for the year ended December 31, 2023. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

Universal Health Services, Inc.
Consolidated Statements of Income
(in thousands, except per share amounts)
(unaudited)
	Three months				Nine months
	ended September 30,				ended September 30,
	2024		2023		2024		2023
Net revenues	$3,963,027		$3,562,774		$11,714,213		$10,578,430
Operating charges:
Salaries, wages and benefits	1,912,308		1,784,870		5,611,304		5,308,476
Other operating expenses	1,090,197		941,219		3,165,483		2,758,484
Supplies expense	390,250		378,667		1,181,886		1,138,950
Depreciation and amortization	149,567		137,195		438,050		422,560
Lease and rental expense	36,540		35,466		108,165		105,775
	3,578,862		3,277,417		10,504,888		9,734,245
Income from operations	384,165		285,357		1,209,325		844,185
Interest expense, net	44,660		53,378		146,385		153,085
Other (income) expense, net	(2,028)		11,472		3,315		31,797
Income before income taxes	341,533		220,507		1,059,625		659,303
Provision for income taxes	75,623		52,499		233,563		159,618
Net income	265,910		168,008		826,062		499,685
Less: Net income (loss) attributable to
noncontrolling interests ("NCI")	7,196		1,019		16,362		(1,732)
Net income attributable to UHS	$258,714		$166,989		$809,700		$501,417
Basic earnings per share attributable to UHS (a)	$3.89		$2.42		$12.11		$7.18
Diluted earnings per share attributable to UHS (a)	$3.80		$2.40		$11.88		$7.09

Universal Health Services, Inc.
Footnotes to Consolidated Statements of Income
(in thousands, except per share amounts)
(unaudited)
	Three months				Nine months
(a) Earnings per share calculation:	ended September 30,				ended September 30,
	2024		2023		2024		2023
Basic and diluted:
Net income attributable to UHS	$258,714		$166,989		$809,700		$501,417
Less: Net income attributable to unvested restricted share grants	0		(52)		(50)		(242)
Net income attributable to UHS - basic and diluted	$258,714		$166,937		$809,650		$501,175
Weighted average number of common shares - basic	66,537		68,867		66,873		69,825
Basic earnings per share attributable to UHS:	$3.89		$2.42		$12.11		$7.18
Weighted average number of common shares	66,537		68,867		66,873		69,825
Add: Other share equivalents	1,571		757		1,297		825
Weighted average number of common shares and equiv. - diluted	68,108		69,624		68,170		70,650
Diluted earnings per share attributable to UHS:	$3.80		$2.40		$11.88		$7.09

Universal Health Services, Inc.
Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")
For the Three Months ended September 30, 2024 and 2023
(in thousands, except per share amounts)
(unaudited)
Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA/Adjusted EBITDA net of NCI")
	Three months ended		% Net		Three months ended		% Net
	September 30, 2024		revenues		September 30, 2023		revenues
Net income attributable to UHS	$258,714				$166,989
Depreciation and amortization	149,567				137,195
Interest expense, net	44,660				53,378
Provision for income taxes	75,623				52,499
EBITDA net of NCI	$528,564		13.3 %		$410,061		11.5 %
Other (income) expense, net	(2,028)				11,472
Adjusted EBITDA net of NCI	$526,536		13.3 %		$421,533		11.8 %
Net revenues	$3,963,027				$3,562,774
Calculation of Adjusted Net Income Attributable to UHS
	Three months ended				Three months ended
	September 30, 2024				September 30, 2023
			Per				Per
	Amount		Diluted Share		Amount		Diluted Share
Net income attributable to UHS	$258,714		$3.80		$166,989		$2.40
Plus/minus after-tax adjustments:
Unrealized (gain) loss on equity securities	(2,275)		(0.03)		10,528		0.15
Impact of ASU 2016-09, net	(3,928)		(0.06)		-		-
Subtotal adjustments	(6,203)		(0.09)		10,528		0.15
Adjusted net income attributable to UHS	$252,511		$3.71		$177,517		$2.55

Universal Health Services, Inc.
Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")
For the Nine Months ended September 30, 2024 and 2023
(in thousands, except per share amounts)
(unaudited)
Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA/Adjusted EBITDA net of NCI")
	Nine months ended		% Net		Nine months ended		% Net
	September 30, 2024		revenues		September 30, 2023		revenues
Net income attributable to UHS	$809,700				$501,417
Depreciation and amortization	438,050				422,560
Interest expense, net	146,385				153,085
Provision for income taxes	233,563				159,618
EBITDA net of NCI	$1,627,698		13.9 %		$1,236,680		11.7 %
Other (income) expense, net	3,315				31,797
Adjusted EBITDA net of NCI	$1,631,013		13.9 %		$1,268,477		12.0 %
Net revenues	$11,714,213				$10,578,430
Calculation of Adjusted Net Income Attributable to UHS
	Nine months ended				Nine months ended
	September 30, 2024				September 30, 2023
			Per				Per
	Amount		Diluted Share		Amount		Diluted Share
Net income attributable to UHS	$809,700		$11.88		$501,417		$7.09
Plus/minus after-tax adjustments:
Unrealized loss on equity securities	4,038		0.06		23,040		0.33
Impact of ASU 2016-09, net	(15,540)		(0.23)		-		-
Subtotal adjustments	(11,502)		(0.17)		23,040		0.33
Adjusted net income attributable to UHS	$798,198		$11.71		$524,457		$7.42

Universal Health Services, Inc.
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
			September 30,			December 31,
			2024			2023
Assets
Current assets:
Cash and cash equivalents		$	106,077		$	119,439
Accounts receivable, net			2,214,268			2,238,265
Supplies			220,062			216,988
Other current assets			261,549			236,658
Total current assets			2,801,956			2,811,350
Property and equipment			12,448,230			11,777,047
Less: accumulated depreciation			(6,005,664)			(5,652,518)
			6,442,566			6,124,529
Other assets:
Goodwill			3,965,492			3,932,407
Deferred income taxes			121,904			85,626
Right of use assets-operating leases			421,441			433,962
Deferred charges			9,705			6,974
Other			590,784			572,754
Total Assets		$	14,353,848		$	13,967,602
Liabilities and Stockholders' Equity
Current liabilities:
Current maturities of long-term debt		$	38,351		$	126,686
Accounts payable and other liabilities			1,896,234			1,813,015
Operating lease liabilities			72,801			71,600
Federal and state taxes			3,802			2,046
Total current liabilities			2,011,188			2,013,347
Other noncurrent liabilities			660,247			584,007
Operating lease liabilities noncurrent			377,644			382,559
Long-term debt			4,618,060			4,785,783
Redeemable noncontrolling interest			5,623			5,191
UHS common stockholders' equity			6,605,696			6,149,001
Noncontrolling interest			75,390			47,714
Total equity			6,681,086			6,196,715
Total Liabilities and Stockholders' Equity		$	14,353,848		$	13,967,602

Universal Health Services, Inc.
Consolidated Statements of Cash Flows
(in thousands)
(unaudited)
	Nine months
	ended September 30,
	2024		2023
Cash Flows from Operating Activities:
Net income	$826,062		$499,685
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation & amortization	438,050		422,560
Gains on sale of assets and businesses	(5,124)		(6,250)
Costs related to extinguishment of debt	3,158		0
Stock-based compensation expense	72,727		65,702
Changes in assets & liabilities, net of effects from
acquisitions and dispositions:
Accounts receivable	11,703		(193,108)
Accrued interest	(1,762)		60
Accrued and deferred income taxes	(10,949)		(33,240)
Other working capital accounts	1,329		(65,062)
Medicare accelerated payments and deferred CARES Act and other grants	0		1,764
Other assets and deferred charges	(5,621)		48,985
Other	25,732		13,717
Accrued insurance expense, net of commercial premiums paid	175,104		141,414
Payments made in settlement of self-insurance claims	(121,745)		(80,861)
Net cash provided by operating activities	1,408,664		815,366
Cash Flows from Investing Activities:
Property and equipment additions	(697,865)		(536,665)
Proceeds received from sales of assets and businesses	30,219		23,688
Acquisition of businesses and property	0		(3,728)
Outflows from foreign exchange contracts that hedge our net U.K. investment	(35,667)		(7,723)
Decrease in capital reserves of commercial insurance subsidiary	197		0
Net cash used in investing activities	(703,116)		(524,428)
Cash Flows from Financing Activities:
Repayments of long-term debt	(2,471,515)		(54,009)
Additional borrowings	2,210,248		165,000
Financing costs	(9,992)		(308)
Repurchase of common shares	(420,588)		(385,339)
Dividends paid	(40,302)		(41,964)
Issuance of common stock	10,864		9,841
Profit distributions to noncontrolling interests	(5,791)		(5,258)
Sale of ownership interests to minority members	8,959		408
Net cash used in financing activities	(718,117)		(311,629)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	2,696		493
Increase (decrease) in cash, cash equivalents and restricted cash	(9,873)		(20,198)
Cash, cash equivalents and restricted cash, beginning of period	214,470		200,837
Cash, cash equivalents and restricted cash, end of period	$204,597		$180,639
Supplemental Disclosures of Cash Flow Information:
Interest paid	$144,378		$149,247
Income taxes paid, net of refunds	$236,975		$191,189
Noncash purchases of property and equipment	$87,333		$108,412

Universal Health Services, Inc.
Supplemental Statistical Information
(unaudited)
							% Change		% Change
							3 Months ended		9 Months ended
Same Facility:							9/30/2024		9/30/2024
Acute Care Hospitals
Revenues							9.2 %		8.5 %
Adjusted Admissions							1.5 %		3.1 %
Adjusted Patient Days							2.0 %		2.3 %
Revenue Per Adjusted Admission							7.0 %		5.0 %
Revenue Per Adjusted Patient Day							6.5 %		5.8 %
Behavioral Health Hospitals
Revenues							10.5 %		10.6 %
Adjusted Admissions							2.2 %		0.3 %
Adjusted Patient Days							1.8 %		1.7 %
Revenue Per Adjusted Admission							8.0 %		10.1 %
Revenue Per Adjusted Patient Day							8.5 %		8.7 %
UHS Consolidated			Third Quarter Ended				Nine Months Ended
			9/30/2024		9/30/2023		9/30/2024		9/30/2023
Revenues			$3,963,027		$3,562,774		$11,714,213		$10,578,430
EBITDA net of NCI			$528,564		$410,061		$1,627,698		$1,236,680
EBITDA Margin net of NCI			13.3 %		11.5 %		13.9 %		11.7 %
Adjusted EBITDA net of NCI			$526,536		$421,533		$1,631,013		$1,268,477
Adjusted EBITDA Margin net of NCI			13.3 %		11.8 %		13.9 %		12.0 %
Cash Flow From Operations			$332,977		$161,665		$1,408,664		$815,366
Capital Expenditures			$247,932		$200,001		$697,865		$536,665
Days Sales Outstanding							52		58
Debt							$4,656,411		$4,922,629
UHS' Shareholders Equity							$6,605,696		$6,064,915
Debt / Total Capitalization							41.3 %		44.8 %
Debt / EBITDA net of NCI (1)							2.21		2.97
Debt / Adjusted EBITDA net of NCI (1)							2.21		2.83
Debt / Cash From Operations (1)							2.50		4.42
(1) Latest 4 quarters.

Universal Health Services, Inc.
Acute Care Hospital Services
For the Three and Nine months ended
September 30, 2024 and 2023
(in thousands)
(unaudited)
Same Facility Basis - Acute Care Hospital Services
		Three months ended				Three months ended				Nine months ended				Nine months ended
		September 30, 2024				September 30, 2023				September 30, 2024				September 30, 2023
		Amount		% of Net Revenues		Amount		% of Net Revenues		Amount		% of Net Revenues		Amount		% of Net Revenues
Net revenues		$2,147,732		100.0 %		$1,965,985		100.0 %		$6,355,078		100.0 %		$5,858,015		100.0 %
Operating charges:
Salaries, wages and benefits		893,436		41.6 %		854,284		43.5 %		2,609,544		41.1 %		2,517,163		43.0 %
Other operating expenses		598,840		27.9 %		543,584		27.6 %		1,754,999		27.6 %		1,604,084		27.4 %
Supplies expense		332,799		15.5 %		323,580		16.5 %		1,011,602		15.9 %		976,712		16.7 %
Depreciation and amortization		93,752		4.4 %		86,437		4.4 %		278,062		4.4 %		273,646		4.7 %
Lease and rental expense		24,202		1.1 %		24,443		1.2 %		72,308		1.1 %		72,459		1.2 %
Subtotal-operating expenses		1,943,029		90.5 %		1,832,328		93.2 %		5,726,515		90.1 %		5,444,064		92.9 %
Income from operations		204,703		9.5 %		133,657		6.8 %		628,563		9.9 %		413,951		7.1 %
Interest expense, net		1,077		0.1 %		(778)		(0.0) %		3,363		0.1 %		(1,858)		(0.0) %
Other (income) expense, net		(590)		(0.0) %		(490)		0.0 %		(1,348)		(0.0) %		5,723		0.1 %
Income before income taxes		$204,216		9.5 %		$134,925		6.9 %		$626,548		9.9 %		$410,086		7.0 %
All Acute Care Hospital Services
		Three months ended				Three months ended				Nine months ended				Nine months ended
		September 30, 2024				September 30, 2023				September 30, 2024				September 30, 2023
		Amount		% of Net Revenues		Amount		% of Net Revenues		Amount		% of Net Revenues		Amount		% of Net Revenues
Net revenues		$2,245,517		100.0 %		$2,017,288		100.0 %		$6,604,007		100.0 %		$5,993,899		100.0 %
Operating charges:
Salaries, wages and benefits		894,551		39.8 %		854,587		42.4 %		2,612,118		39.6 %		2,534,878		42.3 %
Other operating expenses		699,316		31.1 %		596,834		29.6 %		2,009,231		30.4 %		1,731,750		28.9 %
Supplies expense		332,772		14.8 %		323,475		16.0 %		1,011,460		15.3 %		979,185		16.3 %
Depreciation and amortization		94,522		4.2 %		86,535		4.3 %		279,048		4.2 %		274,165		4.6 %
Lease and rental expense		24,490		1.1 %		24,440		1.2 %		72,638		1.1 %		72,629		1.2 %
Subtotal-operating expenses		2,045,651		91.1 %		1,885,871		93.5 %		5,984,495		90.6 %		5,592,607		93.3 %
Income from operations		199,866		8.9 %		131,417		6.5 %		619,512		9.4 %		401,292		6.7 %
Interest expense, net		1,077		0.0 %		(778)		(0.0) %		3,363		0.1 %		(1,858)		(0.0) %
Other (income) expense, net		(527)		(0.0) %		(211)		(0.0) %		(354)		(0.0) %		6,921		0.1 %
Income before income taxes		$199,316		8.9 %		$132,406		6.6 %		$616,503		9.3 %		$396,229		6.6 %
We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Acute Care Hospital Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2023 and our Form 10-Q for the quarter ended June 30, 2024.
The All Acute Care Hospital Services table summarizes the results of operations for all our acute care operations during the periods presented. These amounts include: (i) our acute care results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months.

Universal Health Services, Inc.
Behavioral Health Care Services
For the Three and Nine months ended
September 30, 2024 and 2023
(in thousands)
(unaudited)
Same Facility - Behavioral Health Care Services
		Three months ended				Three months ended				Nine months ended				Nine months ended
		September 30, 2024				September 30, 2023				September 30, 2024				September 30, 2023
		Amount		% of Net Revenues		Amount		% of Net Revenues		Amount		% of Net Revenues		Amount		% of Net Revenues
Net revenues		$1,672,453		100.0 %		$1,514,017		100.0 %		$4,972,612		100.0 %		$4,494,791		100.0 %
Operating charges:
Salaries, wages and benefits		916,435		54.8 %		842,683		55.7 %		2,679,938		53.9 %		2,494,850		55.5 %
Other operating expenses		313,402		18.7 %		294,788		19.5 %		934,107		18.8 %		869,771		19.4 %
Supplies expense		57,723		3.5 %		55,112		3.6 %		171,594		3.5 %		161,371		3.6 %
Depreciation and amortization		52,075		3.1 %		47,472		3.1 %		149,094		3.0 %		139,358		3.1 %
Lease and rental expense		11,806		0.7 %		10,883		0.7 %		34,908		0.7 %		32,684		0.7 %
Subtotal-operating expenses		1,351,441		80.8 %		1,250,938		82.6 %		3,969,641		79.8 %		3,698,034		82.3 %
Income from operations		321,012		19.2 %		263,079		17.4 %		1,002,971		20.2 %		796,757		17.7 %
Interest expense, net		1,041		0.1 %		1,252		0.1 %		3,076		0.1 %		3,455		0.1 %
Other (income) expense, net		(794)		(0.0) %		(985)		(0.1) %		(2,341)		(0.0) %		(2,294)		(0.1) %
Income before income taxes		$320,765		19.2 %		$262,812		17.4 %		$1,002,236		20.2 %		$795,596		17.7 %
All Behavioral Health Care Services
		Three months ended				Three months ended				Nine months ended				Nine months ended
		September 30, 2024				September 30, 2023				September 30, 2024				September 30, 2023
		Amount		% of Net Revenues		Amount		% of Net Revenues		Amount		% of Net Revenues		Amount		% of Net Revenues
Net revenues		$1,714,914		100.0 %		$1,542,695		100.0 %		$5,102,290		100.0 %		$4,575,378		100.0 %
Operating charges:
Salaries, wages and benefits		919,301		53.6 %		844,244		54.7 %		2,690,118		52.7 %		2,498,338		54.6 %
Other operating expenses		354,331		20.7 %		322,208		20.9 %		1,054,007		20.7 %		949,958		20.8 %
Supplies expense		57,830		3.4 %		55,272		3.6 %		172,031		3.4 %		161,597		3.5 %
Depreciation and amortization		52,452		3.1 %		47,720		3.1 %		150,949		3.0 %		140,117		3.1 %
Lease and rental expense		11,956		0.7 %		10,911		0.7 %		35,235		0.7 %		32,834		0.7 %
Subtotal-operating expenses		1,395,870		81.4 %		1,280,355		83.0 %		4,102,340		80.4 %		3,782,844		82.7 %
Income from operations		319,044		18.6 %		262,340		17.0 %		999,950		19.6 %		792,534		17.3 %
Interest expense, net		1,041		0.1 %		1,252		0.1 %		3,076		0.1 %		3,456		0.1 %
Other (income) expense, net		(861)		(0.1) %		(1,080)		(0.1) %		(2,408)		(0.0) %		(3,139)		(0.1) %
Income before income taxes		$318,864		18.6 %		$262,168		17.0 %		$999,282		19.6 %		$792,217		17.3 %
We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Behavioral Health Care Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2023 and our Form 10-Q for the quarter ended June 30, 2024.
The All Behavioral Health Care Services table summarizes the results of operations for all our behavioral health care facilities during the periods presented. These amounts include: (i) our behavioral health results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months.

Universal Health Services, Inc.
Selected Hospital Statistics
For the Three Months ended
September 30, 2024 and 2023
(unaudited)
AS REPORTED:
		ACUTE						BEHAVIORAL HEALTH
		09/30/24		09/30/23		% change		09/30/24		09/30/23		% change
Hospitals owned and leased		27		27		0.0 %		334		331		0.9 %
Average licensed beds		6,657		6,667		-0.1 %		24,446		24,194		1.0 %
Average available beds		6,485		6,495		-0.2 %		24,346		24,094		1.0 %
Patient days		393,521		384,348		2.4 %		1,630,369		1,600,740		1.9 %
Average daily census		4,277.4		4,177.7		2.4 %		17,721.4		17,399.3		1.9 %
Occupancy-licensed beds		64.3 %		62.7 %		2.5 %		72.5 %		71.9 %		0.8 %
Occupancy-available beds		66.0 %		64.3 %		2.5 %		72.8 %		72.2 %		0.8 %
Admissions		81,731		80,074		2.1 %		121,421		118,487		2.5 %
Length of stay		4.8		4.8		0.3 %		13.4		13.5		-0.6 %
Inpatient revenue		$12,277,563		$10,916,060		12.5 %		$2,835,301		$2,703,478		4.9 %
Outpatient revenue		8,573,270		7,480,353		14.6 %		268,182		259,060		3.5 %
Total patient revenue		20,850,833		18,396,413		13.3 %		3,103,483		2,962,538		4.8 %
Other revenue		266,822		251,985		5.9 %		84,770		81,149		4.5 %
Gross revenue		21,117,655		18,648,398		13.2 %		3,188,253		3,043,687		4.7 %
Total deductions		18,872,138		16,631,110		13.5 %		1,473,339		1,500,992		-1.8 %
Net revenue		$2,245,517		$2,017,288		11.3 %		$1,714,914		$1,542,695		11.2 %
SAME FACILITY:
		ACUTE						BEHAVIORAL HEALTH
		09/30/24		09/30/23		% change		09/30/24		09/30/23		% change
Hospitals owned and leased		27		27		0.0 %		333		333		0.0 %
Average licensed beds		6,657		6,667		-0.1 %		24,277		24,012		1.1 %
Average available beds		6,485		6,495		-0.2 %		24,177		23,912		1.1 %
Patient days		393,521		384,348		2.4 %		1,618,344		1,586,108		2.0 %
Average daily census		4,277.4		4,177.7		2.4 %		17,590.7		17,240.3		2.0 %
Occupancy-licensed beds		64.3 %		62.7 %		2.5 %		72.5 %		71.8 %		0.9 %
Occupancy-available beds		66.0 %		64.3 %		2.5 %		72.8 %		72.1 %		0.9 %
Admissions		81,731		80,074		2.1 %		120,515		117,635		2.4 %
Length of stay		4.8		4.8		0.3 %		13.4		13.5		-0.4 %

Universal Health Services, Inc.
Selected Hospital Statistics
For the Nine Months ended
September 30, 2024 and 2023
(unaudited)
AS REPORTED:
		ACUTE						BEHAVIORAL HEALTH
		09/30/24		09/30/23		% change		09/30/24		09/30/23		% change
Hospitals owned and leased		27		27		0.0 %		334		331		0.9 %
Average licensed beds		6,657		6,697		-0.6 %		24,413		24,203		0.9 %
Average available beds		6,485		6,525		-0.6 %		24,313		24,103		0.9 %
Patient days		1,199,271		1,172,957		2.2 %		4,858,431		4,761,887		2.0 %
Average daily census		4,376.9		4,296.5		1.9 %		17,731.5		17,442.8		1.7 %
Occupancy-licensed beds		65.7 %		64.2 %		2.5 %		72.6 %		72.1 %		0.8 %
Occupancy-available beds		67.5 %		65.8 %		2.5 %		72.9 %		72.4 %		0.8 %
Admissions		247,170		239,300		3.3 %		361,149		358,703		0.7 %
Length of stay		4.9		4.9		0.0 %		13.5		13.3		1.7 %
Inpatient revenue		$37,522,395		$33,278,396		12.8 %		$8,375,470		$8,001,838		4.7 %
Outpatient revenue		25,553,451		22,292,249		14.6 %		833,260		812,467		2.6 %
Total patient revenue		63,075,846		55,570,645		13.5 %		9,208,730		8,814,305		4.5 %
Other revenue		747,424		714,877		4.6 %		247,182		220,393		12.2 %
Gross revenue		63,823,270		56,285,522		13.4 %		9,455,912		9,034,698		4.7 %
Total deductions		57,219,263		50,291,623		13.8 %		4,353,622		4,459,320		-2.4 %
Net revenue		$6,604,007		$5,993,899		10.2 %		$5,102,290		$4,575,378		11.5 %
SAME FACILITY:
		ACUTE						BEHAVIORAL HEALTH
		09/30/24		09/30/23		% change		09/30/24		09/30/23		% change
Hospitals owned and leased		27		27		0.0 %		333		333		0.0 %
Average licensed beds		6,657		6,634		0.3 %		24,189		24,060		0.5 %
Average available beds		6,485		6,462		0.4 %		24,089		23,960		0.5 %
Patient days		1,199,271		1,166,693		2.8 %		4,819,550		4,726,531		2.0 %
Average daily census		4,376.9		4,273.6		2.4 %		17,589.6		17,313.3		1.6 %
Occupancy-licensed beds		65.7 %		64.4 %		2.1 %		72.7 %		72.0 %		1.1 %
Occupancy-available beds		67.5 %		66.1 %		2.1 %		73.0 %		72.3 %		1.1 %
Admissions		247,170		238,237		3.7 %		358,114		356,028		0.6 %
Length of stay		4.9		4.9		0.0 %		13.5		13.3		1.5 %

SOURCE Universal Health Services, Inc.